| 1. |
|
|
| 2. |
- Claesson, Lisbeth, 1955, et al.
(författare)
-
Cognitive impairment after stroke - impact on activities of daily living and costs of care for elderly people. The Göteborg 70+ Stroke Study.
- 2005
-
Ingår i: Cerebrovascular diseases (Basel, Switzerland). - : S. Karger AG. - 1015-9770 .- 1421-9786. ; 19:2, s. 102-9
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND AND PURPOSE: The economic burden of stroke is substantial and is likely to increase with an increasing number of elderly individuals in the population. There is thus a need for information on the use of health care resources and costs among these elderly stroke patients. We examined the impact of the cognitive impairments on the ability to perform activities of daily living (ADL) and utilization and costs of health care in a cohort of elderly stroke patients. METHODS: One hundred and forty-nine patients aged >/=70 years with acute stroke were included. The patients were assessed regarding their ability to carry out ADL and health resource utilization and cost during the first year after stroke. Cognitive impairments were assessed 18 months after the index stroke. RESULTS: Stroke severity in acute stroke and cognitive impairment at 18 months after stroke onset was associated with impairment in ADL and increased costs for utilisation of care during the first year. Patients with cognitive impairment were more dependent on personal assistance in ADL. Costs per patient during the study were three times higher for patients with cognitive impairment. Hospital care, institutional living and different kinds of support from society accounted for the highest costs. CONCLUSIONS: Costs of care utilisation during the first year after stroke were associated with cognitive impairments, stroke severity and dependence in ADL. The results should be interpreted cautiously as the assessment of cognitive function was made 18 months after stroke onset and costs were estimated for the first year after stroke.
|
|
| 3. |
- Lindén, Thomas, 1962, et al.
(författare)
-
Visual neglect and cognitive impairment in elderly patients late after stroke.
- 2005
-
Ingår i: Acta neurologica Scandinavica. - : Hindawi Limited. - 0001-6314 .- 1600-0404. ; 111:3, s. 163-8
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: To investigate the prevalence of visual neglect and its relationship to cognitive impairment and dementia in elderly stroke patients 20 months after stroke. METHODS: Of 243 stroke patients aged 70-91 years, 149 underwent neuropsychiatric testing, 138 with the Star Cancellation Test for visual neglect. RESULTS: Fifteen per cent (n = 21) had visual neglect, 9% (n = 12) severe and 9% (n = 12) lateralized. Cognitive impairments were twice as common in patients with neglect as in patients without it and threefold more common when the neglect was severe. Neglect was related to apraxia, impaired visual field, and a previous stroke. Severe neglect was related to dementia, amnesia and impaired visual field. CONCLUSIONS: Chronic neglect is common after stroke in elderly patients. So are cognitive impairments, especially in those with neglect. This calls for high alertness to impairments in spatial attention when treating patients with dementia and other cognitive impairments.
|
|
| 4. |
|
|
| 5. |
- Lindén, Thomas, 1962, et al.
(författare)
-
APOE is a strong gender-dependant risk factor for post-stroke major depression
- 2009
-
Ingår i: European Stoke Conference, Stockholm, Maj.
-
Konferensbidrag (refereegranskat)abstract
- BACKGROUND: Stroke is a major disease that annually affects 15 million people worldwide. Impaired mood is a common and serious complication. Previous studies indicate that Apolipoprotein E (APOE) alleles differently incur risks for late-life onset depression. The aim of this study was to analyse APOE as a risk factor in men and women for depressive disorders late after stroke. METHODS: Two-hundred and forty-three stroke patients over 70 years of age entered a longitudinal, naturalistic hospital-based study. One hundred and forty nine were assessed for cognitive impairments and depression and 88 were genetically tested one and a half years later. RESULTS: Thirty-three percent had any depression, 15% major depressive disorder. Genotypes 3/2 and 4/2 associated to depression. Major depressive disorder, but not all depression, related strongly to APOE carriership (OR 6.0; 95%CI 1.6 to 22), and was stronger for women (OR 17: 95% CI 1.6 to 174) than for men. CONCLUSION: In this first study to analyse the association between APOE genotypes and post-stroke depression, we found that APOE increased the risk for depression, especially in women. The results call for further studies to confirm and clarify the mechanisms for these effects as well as for the difference between sexes.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Åberg, N David, 1970, et al.
(författare)
-
Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-up.
- 2020
-
Ingår i: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. - : Georg Thieme Verlag KG. - 1439-3646. ; 128:5, s. 303-310
-
Tidskriftsartikel (refereegranskat)abstract
- The association of serum insulin-like growth factor I (s-IGF-I) with favorable outcome after ischemic stroke (IS) beyond 2 years is unknown. We investigated whether the levels of s-IGF-I 3 months post-stroke were associated with functional recovery up to 7 years after IS, considering also mortality and recurrent strokes.Patients (N=324; 65% males; mean age, 55 years) with s-IGF-I levels assessed 3 months after the index IS were included from the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS). The modified Rankin Scale (mRS) was used to evaluate outcomes at 3 months, 2 and 7 years after IS, and recovery was defined as an improvement, no change, or deterioration in the shifts of mRS score. Baseline stroke severity was determined using the National Institutes of Health Stroke Scale (NIHSS).The mRS score distributions were better in the above-median s-IGF-I group (>146.7ng/ml). The s-IGF-I level was not associated with recurrent stroke (N=79) or death (N=44), although it correlated with recovery (r=0.12, P=0.035). In the regression analysis, s-IGF-I associated with recovery between 3 months and 7 years (but not between 2 and 7 years). The associations did not withstand adjustment for age and sex. For comparison, the corresponding associations between 3 months and 2 years withstood all adjustments.The association for s-IGF-I with long-term post-stroke recovery persists after 7 years, which is also reflected in the mRS score distributions at all time-points. The effects are however modest, and not driven by mortality or recurrent stroke.
|
|
| 9. |
|
|
| 10. |
|
|
